Elsevier’s Answer to the Impact Factor

“CiteScore,” which ranks twice as many journals compared with publications assigned impact factors, makes its debut during a contentious time for journal metrics.

Written byJoshua A. Krisch
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

PIXABAY, JACKMAC34

The impact factor (IF) has arguably never been less popular. But now, the controversial journal metric has another potential rival. On December 8, Elsevier introduced its own system for ranking journals, called CiteScore. It is similar to the existing IF metric, but covers twice as many journals and is based on the Scopus database, which is more comprehensive than the IF’s data source, Web of Science.

CiteScore has a few quirks in its methodology that will affect prominent journal rankings. The Lancet, for instance, ranks fourth in the world under the IF, according to Nature, but ranks below 200th in the CiteScore system. That’s because, while both metrics calculate impact by dividing the number of citations by the total number of articles published, CiteScore includes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies